Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity

Pharmaceutical Research

Volumn 31, Issue 9, 2014, Pages 2393-2403

  Ma, Yunzhe ^a   Tao, Wenqian ^a   Krebs, Shelly J ^b   Sutton, William F ^b   Haigwood, Nancy L ^b   Gill, Harvinder S ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

lip vaccination; mucosal vaccination; oral cavity vaccination; oral HIV; tongue vaccination

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OVALBUMIN;

ANIMAL; BLOOD; DEVICES; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MOUTH; MUCOSAL IMMUNITY; NEEDLE; ORAL DRUG ADMINISTRATION; RABBIT; SALIVA; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HIV; HIV ANTIGENS; HIV INFECTIONS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MOUTH; NEEDLES; OVALBUMIN; RABBITS; SALIVA; VACCINATION;

EID: 84895776475     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1335-1     Document Type: Article

References (31)

1. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol. 2012;12:592-605.
2. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148-58.
3. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11:S45-53.
4. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J Control Release. 2006;114:15-40.
5. Lu FX, Jacobson RS. Oral mucosal immunity and HIV/SIV infection. J Dent Res. 2007;86:216-26.
6. Brandtzaeg P. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med. 2011;183:1595-604.
7. Brandtzaeg P. Immune functions of nasopharyngeal lymphoid tissue. Adv Otorhinolaryngol. 2011;72:20-4.
8. Hasseus B, Jontell M, Bergenholtz G, Dahlgren UI. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol. 2004;136:483-9.
9. Farquhar C, VanCott T, Bosire R, Bermudez C, Mbori-Ngacha D, Lohman-Payne B, et al. Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya. Clin Exp Immunol. 2008;153:37-43.
10. Luzuriaga K, Newell ML, Dabis F, Excler JL, Sullivan JL. Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities. Lancet. 2006;368:511-21.
11. Koga T, Oho T, Shimazaki Y, Nakano Y. Immunization against dental caries. Vaccine. 2002;20:2027-44.
12. Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. J Control Release. 2009;140:2-11.
13. Çuburu N, Kweon M-N, Song J-H, Hervouet C, Luci C, Sun J-B, et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine. 2007;25:8598-610.
14. Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, et al. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci U S A. 2008;105:1644-9.
15. Cui Z, Mumper RJ. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm Res. 2002;19:947-53.
16. Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR, et al. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U S A. 2009;106:18936-41.
17. Gill HS, Prausnitz MR. Coating formulations for microneedles. Pharm Res. 2007;24:1369-80.
18. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release. 2007;117:227-37.
19. Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR. Transdermal delivery of insulin using microneedles in vivo. Pharm Res. 2004;21:947-52.
20. Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A. 2008;105:2058-63.
21. Zhu Q, Zarnitsyn VG, Ye L, Wen Z, Gao Y, Pan L, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A. 2009;106:7968-73.
22. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369-93.
23. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release. 2010;142:187-95.
24. Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker 3rd JP, et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis. 2005;191:278-88.
25. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005;1:106-11.
26. Desvignes C, Esteves F, Etchart N, Bella C, Czerkinsky C, Kaiserlian D. The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo. Clin Exp Immunol. 1998;113:386-93.
27. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585-94.
28. Jaworski JP, Krebs SJ, Trovato M, Kovarik DN, Brower Z, Sutton WF, et al. Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells. PloS One. 2012;7:e31464.
29. Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release. 2004;97:503-11.
30. Shim BS, Choi YK, Yun CH, Lee EG, Jeon YS, Park SM, et al. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PloS One. 2011;6:e27953.
31. Jun S, Clapp B, Zlotkowska D, Hoyt T, Holderness K, Maddaloni M, et al. Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication. Int Immunol. 2012;24:117-28.